The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population

Pancreatology

Volumn 16, Issue 4, 2016, Pages 578-583

  Zhou, Jie ^a   Li, Ming Long ^a   Zhang, Dan Dan ^a   Lin, Hai Yan ^a   Dai, Xiao Hua ^a   Sun, Xiang Lan ^a   Li, Jian Ting ^b   Song, Li Yuan ^a   Peng, Hui ^a   Wen, Meng Meng ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Hepatic steatosis; Metabolic syndrome; Obesity; Pancreatic steatosis; Trans abdominal sonography

Indexed keywords

ADULT; ARTICLE; CHINESE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PANCREAS STEATOSIS; PREVALENCE; PRIORITY JOURNAL; STEATOSIS; AGE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS; CHINA; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; OBESITY, ABDOMINAL; PANCREAS; PANCREATIC DISEASES; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PANCREAS; PANCREATIC DISEASES; PREVALENCE; RISK FACTORS; SEX FACTORS; ULTRASONOGRAPHY;

EID: 84961926605     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2016.03.008     Document Type: Article

References (35)

1. [1] Olufadi, R., Byrne, C.D., Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 61 (2008), 697–706.
2. [2] van Herpen, N.A., Schrauwen-Hinderling, V.B., Lipid accumulation in non-adipose tissue and lipotoxiicty. Physiol Behav 94 (2008), 231–241.
3. [3] Després, J.P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 444 (2006), 881–887.
4. [4] Virkamäki, A., Korsheninnikova, E., Seppälä-Lindroos, A., Vehkavaara, S., Goto, T., Halavaara, J., et al. Intramyocellular lipid is associated with resistance to in vivo insulinactions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50 (2001), 2337–2343.
5. [5] Samuel, V.T., Liu, Z.X., Qu, X., Elder, B.D., Bilz, S., Befroy, D., et al. Mechanism of hepatic insulin resistance in nonalcoholic fatty liver disease. J Biol Chem 279 (2004), 32345–32353.
6. [6] Kanazawa, M., Yoshiike, N., Osaka, T., Numba, Y., Zimmet, P., Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 11 (2002), S732–S737.
7. [7] Oh, S.W., Obesity and metabolic syndrome in Korea. Diabetes Metab J 35 (2011), 561–566.
8. [8] Fan, J.G., Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Chin J Hepatol 18 (2010), 163–166.
9. [9] Sepe, P.S., Ohri, A., Sanaka, S., Berzin, T.M., Sekhon, S., Bennet, G., et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 73 (2011), 987–993.
10. [10] Lee, J.S., Kim, S.H., Jun, D.W., Han, J.H., Jang, E.C., Park, J.Y., et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 15 (2009), 1869–1875.
11. [11] Expert Panel on Metabolic Syndrome of Chinese Diabetes Society, Recommendations on metabolic syndrome of Chinese Diabetes Society (Chinese). Chin J Diabetes 12 (2004), 156–161.
12. [12] Grundy, S.M., Cleeman, J.I., Daniels, S.R., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005), 2735–2752.
13. [13] American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33:Suppl 1 (2010), S62–S69.
14. [14] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
15. [15] Ogilvie, R., The island of langerhans in 19 cases of obesity. J Pathol 37 (1933), 473–481.
16. [16] Stamm, B.H., Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol 15 (1984), 677–683.
17. [17] Olsen, T.S., Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 86A (1978), 367–373.
18. [18] Rader, D.J., Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:3 Suppl 1 (2007), S12–S18.
19. [19] Kovanlikaya, A., Mittelman, S.D., Ward, A., Geffner, M.E., Dorey, F., Gilsanz, V., Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 35 (2005), 601–607.
20. [20] Tachibana, K., Sakurai, K., Yokoh, H., Ishibashi, T., Ishikaea, K., Shirasawa, T., Mutation in insulin receptor attenuates oxidative stress and apoptosis in pancreatic beta-cells induced by nutrition excess: reduced insulin signaling and ROS. Horm Metab Res 47 (2015), 176–183.
21. [21] Zhang, X., Cui, Y., Fang, L., Li, F., Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas 37 (2008), e31–e38.
22. [22] Kharroubi, I., Ladriere, L., Cardozo, A.K., Dogusan, Z., Cnop, M., Eizirik, D.L., Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145 (2004), 5087–5096.
23. [23] Shimabukuro, M., Higa, M., Zhou, Y.T., Wang, M.Y., Newgard, C.B., Unger, R.H., Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273 (1998), 32487–32490.
24. [24] van Raalte, D.H., van der Zijl, N.J., Diamant, M., Pancreatic steatosis in humans: cause or marker of lipotoxicity?. Curr Opin Clin Nutr Metab Care 13 (2010), 478–485.
25. [25] Van der Zijl, N.J., Goossens, G.H., Moors, C.C., Van Raalte, D.H., Muskiet, M.H., Pouwels, P.J., et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96 (2011), 459–467.
26. [26] Smits, M., van Geenen, E., The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8 (2011), 169–177.
27. [27] Fabbrini, E., deHaseth, D., Deivanayagam, S., Mohammed, B.S., Vitola, B.E., Klein, S., Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 17 (2009), 25–29.
28. [28] Pinnick, K.E., Collins, S.C., Londos, C., Ganguier, D., Clark, A., Fielding, B.A., Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity 16 (2008), 522–530.
29. [29] Munigala, S., Conwell, D.L., Gelrud, A., Agarwal, B., Heavy smoking is associated with lower age at first episode of acute pancreatitis and a higher risk of recurrence. Pancreas 44 (2015), 876–881.
30. [30] Rossi, A.P., Fantin, F., Zamboni, G.A., Mazzali, G., Zoico, E., Bambace, C., et al. Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects. Nutr Diabetes, 2, 2012, e32.
31. [31] Cerf, M.E., High fat diet modulation of glucose sensing in the beta-cell. Med Sci Monit 13 (2007), RA12–RA17.
32. [32] Britton, K.A., Fox, C.S., Ectopic fat depots and cardiovascular disease. Circulation 124 (2011), e837–e841.
33. [33] Alzaid, A., Aideyan, O., Nawaz, S., The size of the pancreas in diabetes mellitus. Diabet Med 10 (1993), 759–763.
34. [34] Al-Haddad, M., Khashab, M., Zyromski, N., Pungpapong, S., Wallace, M.B., Scolapio, J., et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 38 (2009), 672–675.
35. [35] Lê, K.A., Ventura, E.E., Fisher, J.Q., Davis, J.N., Weigensberg, M.J., Punyanitya, M., et al. Ethic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory Markers. Diabetes Care 34:2 (2011), 485–490.